PEEL Therapeutics
About:
Peel Therapeutics is a biotech company that develops medicines for cancer and inflammatory diseases.
Website: https://www.peeltx.com/
Top Investors: Activation Capital, National Institutes of Health, Altitude Lab, Carin Canale Theakston, Ryan Watts
Description:
Peel Therapeutics is a clinical-stage biotech business that is creating drugs to improve the lives of patients. Peel (Hebrew for "elephant") began by focusing on cancer-fighting proteins in elephants, and we rapidly realized the power of leveraging evolution's answers to treat and prevent disease. In addition to producing elephant p53 (EP53) nanoparticles for cancer treatment, our team is expanding new cancer and inflammation medicines derived from nature's superpowers.
$25.1M
$1M to $10M
Salt Lake City, Utah, United States
2015-01-01
Joshua Schiffman
1-10
2024-10-28
Private
© 2025 bioDAO.ai